Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18024863

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 Nov 20
First author
Burger RA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Nov 10;32(32):3686
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2007 Nov 20;25(33):5150-2. doi: 10.1200/JCO.2007.13.6150.
    note
    Source null
    related pmid
    18024860
    relationship
    Comment in

Authors and identifiers

  1. name
    Burger RA
    type
    Author
  2. name
    Sill MW
    type
    Author
  3. name
    Monk BJ
    type
    Author
  4. name
    Greer BE
    type
    Author
  5. name
    Sorosky JI
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burger RA
    type
    Author
  2. name
    Sill MW
    type
    Author
  3. name
    Monk BJ
    type
    Author
  4. name
    Greer BE
    type
    Author
  5. name
    Sorosky JI
    type
    Author
bibliography ids
  1. nci-bib-a7035470dd8e3808e465b004
book metadata
content sha256
3b8c901c0fd46e854b25216213ebe33352016af6ef75ab05979dbeeba5c6ae07
document type
citation
dois
  1. 10.1200/JCO.2007.11.5345
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:18024863
immutable id
pubmed:18024863@3b8c901c0fd46e854b25216213ebe33352016af6ef75ab05979dbeeba5c6ae07
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
5165-71
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Nov 10;32(32):3686
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2007 Nov 20;25(33):5150-2. doi: 10.1200/JCO.2007.13.6150.
    note
    Source null
    related pmid
    18024860
    relationship
    Comment in
outcomes validated
false
pmid
18024863
provenance
batch id
89a0f2206e11ca092d02
provider
NCBI PubMed ESummary
record sha256
a6f1011efcdf3e9bca684986f7ce8f7f8ee0f8d9f6b16c9ed2c839a09c0c82dc
response sha256
7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
retrieved at
2026-09-09T23:46:16.784581+00:00
publication date
display
2007 Nov 20
precision
day
year
2007
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18024863/
title
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.

Preserved source evidence · Not medical advice